Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 26 entries
Sorted by: Best Match Show Resources per page
Acute kidney injury in cancer patients and impedance cardiography-assisted renal replacement therapy: Experience from the onconephrology unit of a Chinese tertiary hospital.

Experimental and therapeutic medicine

Wang T, Zhang Y, Li Q, Jia S, Shi C, Niu K, Liu B.
PMID: 29285109
Exp Ther Med. 2017 Dec;14(6):5671-5677. doi: 10.3892/etm.2017.5244. Epub 2017 Oct 02.

Acute kidney injury (AKI) in cancer patients may disrupt anticarcinogenic treatment and greatly increase associated mortality rates. The present study reported on the management of cancer patients with AKI and, from the nephrologic viewpoint, on the significance of fine...

Cite
Wang T, Zhang Y, Li Q, et al. Acute kidney injury in cancer patients and impedance cardiography-assisted renal replacement therapy: Experience from the onconephrology unit of a Chinese tertiary hospital. Exp Ther Med. 2017;14(6):5671-5677doi: 10.3892/etm.2017.5244.
Wang, T., Zhang, Y., Li, Q., Jia, S., Shi, C., Niu, K., & Liu, B. (2017). Acute kidney injury in cancer patients and impedance cardiography-assisted renal replacement therapy: Experience from the onconephrology unit of a Chinese tertiary hospital. Experimental and therapeutic medicine, 14(6), 5671-5677. https://doi.org/10.3892/etm.2017.5244
Wang, Tao, et al. "Acute kidney injury in cancer patients and impedance cardiography-assisted renal replacement therapy: Experience from the onconephrology unit of a Chinese tertiary hospital." Experimental and therapeutic medicine vol. 14,6 (2017): 5671-5677. doi: https://doi.org/10.3892/etm.2017.5244
Wang T, Zhang Y, Li Q, Jia S, Shi C, Niu K, Liu B. Acute kidney injury in cancer patients and impedance cardiography-assisted renal replacement therapy: Experience from the onconephrology unit of a Chinese tertiary hospital. Exp Ther Med. 2017 Dec;14(6):5671-5677. doi: 10.3892/etm.2017.5244. Epub 2017 Oct 02. PMID: 29285109; PMCID: PMC5740768.
Copy Download .nbib Format: NLM
Experience of Autoimmune and autoinflammatory diseases in a Turkish pediatric cohort with primary immunodeficiencies.

Allergologia et immunopathologia

Özcan D, Serbes M, Ekinci RMK, Çetinkaya SB, Şaşihüseyinoğlu AŞ, Bişgin A, Altıntaş DU.
PMID: 34761650
Allergol Immunopathol (Madr). 2021 Nov 01;49(6):1-7. doi: 10.15586/aei.v49i6.450. eCollection 2021.

BACKGROUND: Primary immunodeficiency diseases (PID) are the diseases characterized by a dysfunction of the immune system. Affected patients share a different phenotype such as chronic infections, allergy, autoimmunity, and autoinflammation.METHODS: In all, 433 children with PID were enrolled in...

Cite
Özcan D, Serbes M, Ekinci RMK, et al. Experience of Autoimmune and autoinflammatory diseases in a Turkish pediatric cohort with primary immunodeficiencies. Allergol Immunopathol (Madr). 2021;49(6):1-7doi: 10.15586/aei.v49i6.450.
Özcan, D., Serbes, M., Ekinci, R. M. K., Çetinkaya, S. B., Şaşihüseyinoğlu, A. �. �., Bişgin, A., & Altıntaş, D. U. (2021). Experience of Autoimmune and autoinflammatory diseases in a Turkish pediatric cohort with primary immunodeficiencies. Allergologia et immunopathologia, 49(6), 1-7. https://doi.org/10.15586/aei.v49i6.450
Özcan, Dilek, et al. "Experience of Autoimmune and autoinflammatory diseases in a Turkish pediatric cohort with primary immunodeficiencies." Allergologia et immunopathologia vol. 49,6 (2021): 1-7. doi: https://doi.org/10.15586/aei.v49i6.450
Özcan D, Serbes M, Ekinci RMK, Çetinkaya SB, Şaşihüseyinoğlu AŞ, Bişgin A, Altıntaş DU. Experience of Autoimmune and autoinflammatory diseases in a Turkish pediatric cohort with primary immunodeficiencies. Allergol Immunopathol (Madr). 2021 Nov 01;49(6):1-7. doi: 10.15586/aei.v49i6.450. eCollection 2021. PMID: 34761650.
Copy Download .nbib Format: NLM
IgD promotes pannus formation by activating Wnt5A-Fzd5-CTHRC1-NF-κB signaling pathway in FLS of CIA rats and the regulation of IgD-Fc-Ig fusion protein.

International immunopharmacology

Tai Y, Zhu Y, Mei D, Wang H, Yu Q, Hong C, Cai X, Xu L, Ge J, Liang F, Jiang C, Xue Z, Hu L, Liu R, Zhang T, Wang P, Zhang X, Zhang F, Wei W, Zhang L.
PMID: 34688134
Int Immunopharmacol. 2021 Dec;101:108261. doi: 10.1016/j.intimp.2021.108261. Epub 2021 Oct 20.

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by joint inflammation, synovial hyperplasia, cartilage degeneration, bone erosion, and pannus. Immunoglobulin D (IgD) plays an important role in autoimmune diseases although the content of it in vivo is low....

Cite
Tai Y, Zhu Y, Mei D, et al. IgD promotes pannus formation by activating Wnt5A-Fzd5-CTHRC1-NF-κB signaling pathway in FLS of CIA rats and the regulation of IgD-Fc-Ig fusion protein. Int Immunopharmacol. 2021;101:108261doi: 10.1016/j.intimp.2021.108261.
Tai, Y., Zhu, Y., Mei, D., Wang, H., Yu, Q., Hong, C., Cai, X., Xu, L., Ge, J., Liang, F., Jiang, C., Xue, Z., Hu, L., Liu, R., Zhang, T., Wang, P., Zhang, X., Zhang, F., Wei, W., & Zhang, L. (2021). IgD promotes pannus formation by activating Wnt5A-Fzd5-CTHRC1-NF-κB signaling pathway in FLS of CIA rats and the regulation of IgD-Fc-Ig fusion protein. International immunopharmacology, 101108261. https://doi.org/10.1016/j.intimp.2021.108261
Tai, Yu, et al. "IgD promotes pannus formation by activating Wnt5A-Fzd5-CTHRC1-NF-κB signaling pathway in FLS of CIA rats and the regulation of IgD-Fc-Ig fusion protein." International immunopharmacology vol. 101 (2021): 108261. doi: https://doi.org/10.1016/j.intimp.2021.108261
Tai Y, Zhu Y, Mei D, Wang H, Yu Q, Hong C, Cai X, Xu L, Ge J, Liang F, Jiang C, Xue Z, Hu L, Liu R, Zhang T, Wang P, Zhang X, Zhang F, Wei W, Zhang L. IgD promotes pannus formation by activating Wnt5A-Fzd5-CTHRC1-NF-κB signaling pathway in FLS of CIA rats and the regulation of IgD-Fc-Ig fusion protein. Int Immunopharmacol. 2021 Dec;101:108261. doi: 10.1016/j.intimp.2021.108261. Epub 2021 Oct 20. PMID: 34688134.
Copy Download .nbib Format: NLM
"D" is for Dilemma.

Cureus

Kumar P, Borz-Baba C, Raissi S.
PMID: 31720145
Cureus. 2019 Sep 16;11(9):e5669. doi: 10.7759/cureus.5669.

Immunoglobulin D (IgD) monoclonal gammopathy is a rare subtype of multiple myeloma (MM) associated with a worse prognosis compared with other variants of MM. A 61-year-old man with no known past medical history presented with complaints of abdominal pain,...

Cite
Kumar P, Borz-Baba C, Raissi S. "D" is for Dilemma. Cureus. 2019;11(9):e5669doi: 10.7759/cureus.5669.
Kumar, P., Borz-Baba, C., & Raissi, S. (2019). "D" is for Dilemma. Cureus, 11(9), e5669. https://doi.org/10.7759/cureus.5669
Kumar, Pirkash, et al. ""D" is for Dilemma." Cureus vol. 11,9 (2019): e5669. doi: https://doi.org/10.7759/cureus.5669
Kumar P, Borz-Baba C, Raissi S. "D" is for Dilemma. Cureus. 2019 Sep 16;11(9):e5669. doi: 10.7759/cureus.5669. PMID: 31720145; PMCID: PMC6823037.
Copy Download .nbib Format: NLM
IgD multiple myeloma with central nervous system involvement: A case report and literature review.

Molecular and clinical oncology

Chen Y, Qiu Y, Fu H, Li J, Chen L, Liao S, Liu T.
PMID: 34462654
Mol Clin Oncol. 2021 Oct;15(4):198. doi: 10.3892/mco.2021.2360. Epub 2021 Aug 04.

Central nervous system (CNS) involvement is a rare manifestation of multiple myeloma (MM) and the optimal management strategies have yet to be determined. The aim of the present study was to describe the case of a 47-year-old male patient...

Cite
Chen Y, Qiu Y, Fu H, et al. IgD multiple myeloma with central nervous system involvement: A case report and literature review. Mol Clin Oncol. 2021;15(4):198doi: 10.3892/mco.2021.2360.
Chen, Y., Qiu, Y., Fu, H., Li, J., Chen, L., Liao, S., & Liu, T. (2021). IgD multiple myeloma with central nervous system involvement: A case report and literature review. Molecular and clinical oncology, 15(4), 198. https://doi.org/10.3892/mco.2021.2360
Chen, Yi, et al. "IgD multiple myeloma with central nervous system involvement: A case report and literature review." Molecular and clinical oncology vol. 15,4 (2021): 198. doi: https://doi.org/10.3892/mco.2021.2360
Chen Y, Qiu Y, Fu H, Li J, Chen L, Liao S, Liu T. IgD multiple myeloma with central nervous system involvement: A case report and literature review. Mol Clin Oncol. 2021 Oct;15(4):198. doi: 10.3892/mco.2021.2360. Epub 2021 Aug 04. PMID: 34462654; PMCID: PMC8375031.
Copy Download .nbib Format: NLM
NF-κB signaling induces inductive expression of the downstream molecules and IgD gene in the freshwater carp, .

3 Biotech

Banerjee R, Samanta M, Das S.
PMID: 33014688
3 Biotech. 2020 Oct;10(10):445. doi: 10.1007/s13205-020-02435-7. Epub 2020 Sep 19.

Toll-like receptors (TLRs) in innate immune system act as primary sensors in detecting the microbial components and activate their signaling cascades to induce NF-κB (nuclear factor NF-κB) towards the augmentation of immunoglobulin (Ig) synthesis. To gain insights into the...

Cite
Banerjee R, Samanta M, Das S. NF-κB signaling induces inductive expression of the downstream molecules and IgD gene in the freshwater carp, . 3 Biotech. 2020;10(10):445doi: 10.1007/s13205-020-02435-7.
Banerjee, R., Samanta, M., & Das, S. (2020). NF-κB signaling induces inductive expression of the downstream molecules and IgD gene in the freshwater carp, . 3 Biotech, 10(10), 445. https://doi.org/10.1007/s13205-020-02435-7
Banerjee, Rajanya, et al. "NF-κB signaling induces inductive expression of the downstream molecules and IgD gene in the freshwater carp, ." 3 Biotech vol. 10,10 (2020): 445. doi: https://doi.org/10.1007/s13205-020-02435-7
Banerjee R, Samanta M, Das S. NF-κB signaling induces inductive expression of the downstream molecules and IgD gene in the freshwater carp, . 3 Biotech. 2020 Oct;10(10):445. doi: 10.1007/s13205-020-02435-7. Epub 2020 Sep 19. PMID: 33014688; PMCID: PMC7502101.
Copy Download .nbib Format: NLM
Early stage IgD multiple myeloma in a 50-year-old man.

Proceedings (Baylor University. Medical Center)

Lake Littlejohn C, Whiteley A, Stone MJ.
PMID: 32313482
Proc (Bayl Univ Med Cent). 2019 Dec 23;33(2):263-265. doi: 10.1080/08998280.2019.1698878. eCollection 2020 Apr.

We present the case of a 50-year-old Hispanic man who presented to the emergency department with an acute right femur fracture after 3 months of intermittent discomfort in the right leg. He was eventually diagnosed with immunoglobulin D (IgD)...

Cite
Lake Littlejohn C, Whiteley A, Stone MJ. Early stage IgD multiple myeloma in a 50-year-old man. Proc (Bayl Univ Med Cent). 2019;33(2):263-265doi: 10.1080/08998280.2019.1698878.
Lake Littlejohn, C., Whiteley, A., & Stone, M. J. (2020). Early stage IgD multiple myeloma in a 50-year-old man. Proceedings (Baylor University. Medical Center), 33(2), 263-265. https://doi.org/10.1080/08998280.2019.1698878
Lake Littlejohn, C, et al. "Early stage IgD multiple myeloma in a 50-year-old man." Proceedings (Baylor University. Medical Center) vol. 33,2 (2020): 263-265. doi: https://doi.org/10.1080/08998280.2019.1698878
Lake Littlejohn C, Whiteley A, Stone MJ. Early stage IgD multiple myeloma in a 50-year-old man. Proc (Bayl Univ Med Cent). 2019 Dec 23;33(2):263-265. doi: 10.1080/08998280.2019.1698878. eCollection 2020 Apr. PMID: 32313482; PMCID: PMC7155962.
Copy Download .nbib Format: NLM
Immunoglobulin D Multiple Myeloma, Plasma Cell Leukemia and Chronic Myelogenous Leukemia in a Single Patient Treated Simultaneously with Lenalidomide, Bortezomib, Dexamethasone and Imatinib.

Hematology reports

Ali N, Pickens PV, Auerbach HE.
PMID: 27103978
Hematol Rep. 2016 Mar 17;8(1):6295. doi: 10.4081/hr.2016.6295. eCollection 2016 Mar 17.

Multiple myeloma (MM) is a neoplastic lymphoproliferative disorder characterized by uncontrolled monoclonal plasma cell proliferation. Among different isotypes of MM, immunoglobulin D (IgD) MM is very rare, representing only 1 to 2% of all isotypes. Chronic myelogenous leukemia (CML)...

Cite
Ali N, Pickens PV, Auerbach HE. Immunoglobulin D Multiple Myeloma, Plasma Cell Leukemia and Chronic Myelogenous Leukemia in a Single Patient Treated Simultaneously with Lenalidomide, Bortezomib, Dexamethasone and Imatinib. Hematol Rep. 2016;8(1):6295doi: 10.4081/hr.2016.6295.
Ali, N., Pickens, P. V., & Auerbach, H. E. (2016). Immunoglobulin D Multiple Myeloma, Plasma Cell Leukemia and Chronic Myelogenous Leukemia in a Single Patient Treated Simultaneously with Lenalidomide, Bortezomib, Dexamethasone and Imatinib. Hematology reports, 8(1), 6295. https://doi.org/10.4081/hr.2016.6295
Ali, Naveed, et al. "Immunoglobulin D Multiple Myeloma, Plasma Cell Leukemia and Chronic Myelogenous Leukemia in a Single Patient Treated Simultaneously with Lenalidomide, Bortezomib, Dexamethasone and Imatinib." Hematology reports vol. 8,1 (2016): 6295. doi: https://doi.org/10.4081/hr.2016.6295
Ali N, Pickens PV, Auerbach HE. Immunoglobulin D Multiple Myeloma, Plasma Cell Leukemia and Chronic Myelogenous Leukemia in a Single Patient Treated Simultaneously with Lenalidomide, Bortezomib, Dexamethasone and Imatinib. Hematol Rep. 2016 Mar 17;8(1):6295. doi: 10.4081/hr.2016.6295. eCollection 2016 Mar 17. PMID: 27103978; PMCID: PMC4815947.
Copy Download .nbib Format: NLM
Immunoglobulin D-λ/λ biclonal multiple myeloma: A case report.

World journal of clinical cases

He QL, Meng SS, Yang JN, Wang HC, Li YM, Li YX, Lin XH.
PMID: 33889623
World J Clin Cases. 2021 Apr 16;9(11):2576-2583. doi: 10.12998/wjcc.v9.i11.2576.

BACKGROUND: Immunoglobulin D (IgD) multiple myeloma (MM) is a rare subtype of MM and commonly occurs in younger subjects but at a later stage of the International Staging System (ISS) when admitted. As a special type of IgD myeloma,...

Cite
He QL, Meng SS, Yang JN, et al. Immunoglobulin D-λ/λ biclonal multiple myeloma: A case report. World J Clin Cases. 2021;9(11):2576-2583doi: 10.12998/wjcc.v9.i11.2576.
He, Q. L., Meng, S. S., Yang, J. N., Wang, H. C., Li, Y. M., Li, Y. X., & Lin, X. H. (2021). Immunoglobulin D-λ/λ biclonal multiple myeloma: A case report. World journal of clinical cases, 9(11), 2576-2583. https://doi.org/10.12998/wjcc.v9.i11.2576
He, Qiao-Ling, et al. "Immunoglobulin D-λ/λ biclonal multiple myeloma: A case report." World journal of clinical cases vol. 9,11 (2021): 2576-2583. doi: https://doi.org/10.12998/wjcc.v9.i11.2576
He QL, Meng SS, Yang JN, Wang HC, Li YM, Li YX, Lin XH. Immunoglobulin D-λ/λ biclonal multiple myeloma: A case report. World J Clin Cases. 2021 Apr 16;9(11):2576-2583. doi: 10.12998/wjcc.v9.i11.2576. PMID: 33889623; PMCID: PMC8040188.
Copy Download .nbib Format: NLM
Immunoglobulin D Multiple Myeloma With Rapidly Progressing Renal Failure.

Journal of clinical medicine research

Modi J, Kamal J, Eter A, El-Sayegh S, El-Charabaty E.
PMID: 26124916
J Clin Med Res. 2015 Aug;7(8):653-5. doi: 10.14740/jocmr2210w. Epub 2015 Jun 09.

Immunoglobulin D (IgD) multiple myeloma (MM) is a very rare form of myeloma affecting less than 2% of all myeloma patients. It has a multiorgan involvement with renal failure being the key feature. We present here a case of...

Cite
Modi J, Kamal J, Eter A, et al. Immunoglobulin D Multiple Myeloma With Rapidly Progressing Renal Failure. J Clin Med Res. 2015;7(8):653-5doi: 10.14740/jocmr2210w.
Modi, J., Kamal, J., Eter, A., El-Sayegh, S., & El-Charabaty, E. (2015). Immunoglobulin D Multiple Myeloma With Rapidly Progressing Renal Failure. Journal of clinical medicine research, 7(8), 653-5. https://doi.org/10.14740/jocmr2210w
Modi, Jwalant, et al. "Immunoglobulin D Multiple Myeloma With Rapidly Progressing Renal Failure." Journal of clinical medicine research vol. 7,8 (2015): 653-5. doi: https://doi.org/10.14740/jocmr2210w
Modi J, Kamal J, Eter A, El-Sayegh S, El-Charabaty E. Immunoglobulin D Multiple Myeloma With Rapidly Progressing Renal Failure. J Clin Med Res. 2015 Aug;7(8):653-5. doi: 10.14740/jocmr2210w. Epub 2015 Jun 09. PMID: 26124916; PMCID: PMC4471757.
Copy Download .nbib Format: NLM
Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture.

Case reports in oncology

Al Hadidi S, Katato K, Bachuwa G.
PMID: 28512409
Case Rep Oncol. 2017 Mar 29;10(1):272-275. doi: 10.1159/000466687. eCollection 2017.

Immunoglobulin D multiple myeloma is a rare type of multiple myeloma that usually presents as bone pain, fatigue, or weight loss. We report a case of immunoglobulin D multiple myeloma in a 53-year-old Caucasian male patient with previous medical...

Cite
Al Hadidi S, Katato K, Bachuwa G. Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture. Case Rep Oncol. 2017;10(1):272-275doi: 10.1159/000466687.
Al Hadidi, S., Katato, K., & Bachuwa, G. (2017). Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture. Case reports in oncology, 10(1), 272-275. https://doi.org/10.1159/000466687
Al Hadidi, Samer, et al. "Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture." Case reports in oncology vol. 10,1 (2017): 272-275. doi: https://doi.org/10.1159/000466687
Al Hadidi S, Katato K, Bachuwa G. Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture. Case Rep Oncol. 2017 Mar 29;10(1):272-275. doi: 10.1159/000466687. eCollection 2017. PMID: 28512409; PMCID: PMC5422729.
Copy Download .nbib Format: NLM
Immunoglobulin D and its encoding genes: An updated review.

Developmental and comparative immunology

Wan Z, Zhao Y, Sun Y.
PMID: 34237381
Dev Comp Immunol. 2021 Nov;124:104198. doi: 10.1016/j.dci.2021.104198. Epub 2021 Jul 05.

Since the identification of a functional Cδ gene in ostriches, immunoglobulin (Ig) D has been considered to be an extremely evolutionarily conserved Ig isotype besides the IgM found in all classes of jawed vertebrates. However, in contrast to IgM...

Cite
Wan Z, Zhao Y, Sun Y. Immunoglobulin D and its encoding genes: An updated review. Dev Comp Immunol. 2021;124:104198doi: 10.1016/j.dci.2021.104198.
Wan, Z., Zhao, Y., & Sun, Y. (2021). Immunoglobulin D and its encoding genes: An updated review. Developmental and comparative immunology, 124104198. https://doi.org/10.1016/j.dci.2021.104198
Wan, Zihui, et al. "Immunoglobulin D and its encoding genes: An updated review." Developmental and comparative immunology vol. 124 (2021): 104198. doi: https://doi.org/10.1016/j.dci.2021.104198
Wan Z, Zhao Y, Sun Y. Immunoglobulin D and its encoding genes: An updated review. Dev Comp Immunol. 2021 Nov;124:104198. doi: 10.1016/j.dci.2021.104198. Epub 2021 Jul 05. PMID: 34237381.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 26 entries